Korea

KeyZell start-up plans to reach 5 million euros in private investment and become the new biotech unicorn

MADRID, March 17, 2022 /PRNewswire/ -- KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, has just opened a private financing round which expects to achieve5 million euros to boost its projects and consolidate itself as one of the biotech sta...

2022-03-17 15:30 2508

EW Nutrition receives FAMI-QS certification in Australia

SINGAPORE, March 17, 2022 /PRNewswire/ -- With the implementation and maintenance of their Feed Safety and Quality Management System, including Good Manufacturing Practice (GMP), EW Nutrition has achieved FAMI-QS certification for its management system inAustralia. FAMI-QS is a pre-eminent quali...

2022-03-17 14:00 1792

ilooda launches hyzer me, a next-generation lifting device

SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Botox, filler are considered to be the latest cosmetic procedures to satisfy people's desire to look younger and more beautiful. As the lifting operation has lately drawn the attention of the world, a leading medical device manufacturer ofSouth K...

2022-03-17 09:00 1765

Breakthrough Study Validates Artificial Intelligence as a Novel Biomarker in Predicting Immunotherapy Response - Published in Journal of Clinical Oncology

* Lunit's latest study provides evidence for Lunit SCOPE IO's ability to predict immunotherapy response * This is the first study that adopted AI technology to define the tumor immune phenotype and to demonstrate its ability in predicting treatment outcomes of anti-PD-L1 therapy SEOUL, South ...

2022-03-16 21:09 1841

Chang Il-Moo, a former head of R&D department at KGC, wins James A. Duke award from the American Botanical Council

SEOUL, South Korea and ANAHEIM, Calif., March 16, 2022 /PRNewswire/ -- Chang Il-Moo, who successively served as the head of R&D department at the Korea Ginseng Corporation (KGC, CEOKim Jae-Su), won the 2021 Duke Award, the top writing award granted by the American Botanical Council (ABC), forA Hi...

2022-03-16 15:15 1582

DEKRA signed Memorandum of Understanding (MoU) with Korea Testing Laboratory (KTL)

SEOUL, South Korea, March 16, 2022 /PRNewswire/ -- DEKRA is pleased to announce the signing of a Memorandum of Understanding (MoU) with Korea Testing Laboratory (KTL) to develop cooperation opportunities within the scope of testing and certification services. The areas of interest cover explosion...

2022-03-16 10:56 2663

New Legatus Class Now Available in Black Desert Mobile

SEOUL, South Korea, March 16, 2022 /PRNewswire/ -- Pearl Abyss announced today that the new Legatus class is now available inBlack Desert Mobile. Legendary Dream Horse "Doom" has also arrived to accompany Adventurers. [Pearl Abyss] New Legatus ...

2022-03-16 10:00 2256

PLINTRON WINS 'CLOUD INITIATIVE OF THE YEAR' AT THE ASIAN TELECOM AWARDS 2022

SINGAPORE, March 16, 2022 /PRNewswire/ -- The Asian Telecom Awards, which aims to recognise the achievements of telecommunication companies has announced Plintron as the winner of Cloud Initiative of the year 2022 in its latest awards ceremony. This was awarded for successful implementation of Pl...

2022-03-16 08:00 2613

ROKIT Healthcare's Latest Paper About Its AI Technology Has Been Accepted to CVPR 2022

SEOUL, South Korea, March 15, 2022 /PRNewswire/ -- ROKIT Healthcare, a global hyper-personalized organ regeneration company, announced onMarch 7th that its paper about the "AI and 3D bioprinting convergence technology for regenerative treatments" has been accepted to 2022 IEEE/CVF Conference on C...

2022-03-15 20:00 1172

How events go through pandemic; Voithru holds 1st Metaverse award ceremony

SEOUL, South Korea, March 15, 2022 /PRNewswire/ -- Voithru, a content-tech startup, held an awards ceremony this February for 'Webtoon(a type of digital comic)translation competition'. The ceremony was held in the Metaverse platform 'Gather-town' which was suited for the pandemic and also for the...

2022-03-15 13:33 2079

NuclixBio Announces a Collaborative Research Agreement with PharmAbcine

SEOUL, South Korea, March 14, 2022 /PRNewswire/ -- NuclixBio Inc., a South Korean biotech company that focuses on research and development of mRNA therapeutics, announced today that it has signed a Collaborative Research Agreement with PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech...

2022-03-14 20:00 1767

Beyond Music, the Korean version of Hipgnosis, to conquer the global music IP market by taking over a large-scale music catalog management company

* Beyond Music is the largest management company for music intellectual properties (IPs) in S. Korea * They have taken over 'FNC Investment', the second largest music IP management company in S. Korea, and made a strategic partnership with Dreamus Company, a subsidiary of SK Square * They h...

2022-03-14 20:00 1608

VVDN Enters Into a Strategic Alliance With Blue Star For Co-Developing and Manufacturing New-Generation Controllers For Air Conditioners

GURUGRAM, India, March 14, 2022 /PRNewswire/ -- VVDN Technologies, a premier product engineering and manufacturing company, today announced its strategic alliance withBlue Star, a leading air conditioning and refrigeration company in India. With this alliance, VVDN will be co-developing and manuf...

2022-03-14 13:11 2271

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that...

2022-03-14 08:00 2471

Dot Inc. Announces the World's First Tactile Braille Display, Compatible with iPhone and iPad

* New Dot Pad display from Dot Inc. helps blind/low-vision users feel tactile images in real-time * It will be showcased at the CSUN's Assistive Technology Conference in March 2022 * Dot Pad is now available to developer communities and early adopters on Dot's official website SEOUL, South ...

2022-03-11 22:00 4329

A2Mac1 is pleased to announce the opening of its new Korean and South-east Asia sales office in Seoul, Korea

PARIS, France and SEOUL, South Korea, March 11, 2022 /PRNewswire/ -- To ensure and strengthen its continuing collaboration with its rapidly growing customer based in Korea and the South-east Asian markets, A2Mac1 is pleased to announce the opening of its new office in the center of theSeoul autom...

2022-03-11 09:59 3270

Infosys Becomes Digital Innovation Partner for International Tennis Hall of Fame and Title Sponsor of the Hall of Fame Open

Strategic collaboration to bring technology expertise to reimagine fan experiences and preserve tennis heritage at the historic venue where the first U.S. National Championships were hosted in 1881 NEWPORT, R.I., March 10, 2022 /PRNewswire/ -- Infosys  (NSE: INFY) (BSE:...

2022-03-10 18:49 2463

Ascenda partners with Hyundai Card to support launch of new cards in South Korea

SEOUL, South Korea, March 10, 2022 /PRNewswire/ -- Ascenda, the technology company that makes payments and banking more rewarding, has partnered with Hyundai Card, a leading credit card issuer, to power the launch of a new lineup of consumer and corporate cards on the American Express Network inS...

2022-03-10 18:11 1321

New Online Trading Brokerage Brand XPro Markets Launched

JOHANNESBURG, March 10, 2022 /PRNewswire/ -- Recent months have witnessed another significant growth in the popularity of online trading around the world. With that in mind, global investment firm Ukuchuma Financial Services has announced the launch of its new and much-anticipated trading brand X...

2022-03-10 09:00 2206

Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting

* The abstract of BBT-207 pre-clinical studies is now available at the AACR website * Preclinical data suggests that BBT-207 may have the potential to be positioned as a frontline treatment with the anti-tumor effects in EGFR mutant NSCLC SEONGNAM, South Korea, March 9, 2022 /PRNewswire/ -- B...

2022-03-10 07:00 1451
1 ... 134135136137138139140 ... 274